BioIntelliSense announces FDA clearance of BioSticker vital signs monitoring device

BioIntelliSense announces FDA clearance of BioSticker vital signs monitoring device

DENVER -- BioIntelliSense, Inc., a continuous health monitoring and clinical intelligence company, today announced the U.S. commercial launch of its medical grade Data-as-a-Service (DaaS) platform... Read More

Tuesday January 28, 2020 0 comments Tags: Denver, BioIntelliSense, BioSticker, James Mault